NYMOX PHARMACEUTICAL CORP financial data

Symbol
NYMXF on OTC
Location
Quebec Canada, Quebec, Canada
Fiscal year end
31 December
Latest financial report
20-F - Q4 2024 - 03 Jun 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 94,540,140 shares 1.1%

Income Statement

Label TTM Value / Value Unit Change %
Research And Development Expense $511,000 USD -23%
General And Administrative Expense $142,000 USD -60%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets $654,000 USD 4.3%
Liabilities $7,429,000 USD 96%

Popular Metrics

Label TTM Value / Value Unit Change %
Interest Expense $63,000 USD 186%